Human Vaccines & Immunotherapeutics (Jan 2021)

Vaccine-associated Rubella – a report of two cases and a review of the literature

  • Sean Wei Xiang Ong,
  • Shawn Vasoo,
  • Sapna P. Sadarangani,
  • Lin Cui,
  • Kalisvar Marimuthu,
  • Poh Lian Lim,
  • Jing Wen Kong,
  • Judith Chui Ching Wong,
  • Kim Yoong Puong,
  • Kwai Peng Chan

DOI
https://doi.org/10.1080/21645515.2020.1765623
Journal volume & issue
Vol. 17, no. 1
pp. 224 – 227

Abstract

Read online

We report the clinical characteristics of two adult patients, presenting with a typical erythematous rash consistent with rubella disease after MMR vaccination. Both patients had an uncomplicated clinical course and recovered uneventfully. One patient was confirmed to have vaccine-associated rubella via sequencing of virus isolated in viral culture. The other patient had a pharyngeal swab positive for rubella virus PCR, with sequencing matching the vaccine strain. There are few reports of clinical disease from rubella vaccine-strains in the literature. Previous authors have reported severe disseminated vaccine-associated rubella in both immunodeficient and immunocompetent patients. Further study is required to ascertain the incidence, risk factors, and clinical characteristics of this condition; as well as investigate the extent of horizontal transmission to guide infection control recommendations.

Keywords